Questions you want answered write them down so you dont forget
Tirzepatide, a dual GLP-1/GIP agonist, is already approved as Mounjaro (for type 2 diabetes) and Zepbound (for obesity)
Iyengar has stated that he does not recommend prescribing GLP-1s to women who have just been diagnosed with breast cancer or are undergoing chemotherapy, citing a lack of data as well as concerns that these drugs may worsen side effects of chemotherapy such as nausea
TH, GPX4, or 4-HNE staining of brain section IHC and immunofluorescence was conducted as described previously (43)
After treatment with BN for 3 months, BMI, fasting blood glucose, glycosylated hemoglobin, visceral and subcutaneous fat, silk protein E1, leptin, C-reactive protein (CRP), and tumor necrosis factor decreased significantly
Its the glucagon component